Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 6.03M | $27.0M | 10.61% | +550.0K | 2026-03-31 |
| BlackRock, Inc. | 3.20M | $14.0M | 5.62% | +35.7K | 2026-03-31 |
| AIGH Capital Management LLC | 3.10M | $13.0M | 5.45% | +1.10M | 2026-03-31 |
| Cable Car Capital, LP | 3.01M | $13.0M | 5.29% | +507.3K | 2026-03-31 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2.68M | $11.0M | 4.71% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.16M | $9.0M | 3.81% | -- | 2026-03-31 |
| Propel Bio Management, LLC | 1.33M | $6.0M | 2.34% | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.21M | $5.0M | 2.13% | +72.7K | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 1.13M | $5.0M | 1.99% | +628.4K | 2026-03-31 |
| STATE STREET CORP | 957.3K | $4.0M | 1.68% | +58.9K | 2026-03-31 |
